-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: ACOG Preventive med guidelines and Hep B From: Efrain Ramirez (eramirez@icepr.com) Thu Oct 26 18:46:32 2000 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Richard Chudacoff, MD: "Re: Jim Connerth MD" Previous message: Cheri Van Hoover: "Re: ACOG Preventive med guidelines and Hep B" In reply to: ginny lee BSN, GNM: "Re: ACOG Preventive med guidelines and Hep B" Next in thread: Edgardo Rivera: "Re: ACOG Preventive med guidelines and Hep B" There are no titers --This article is a must - read it - Genital herpes and public health: addressing a global problem. Corey L - JAMA - 2000 Feb 9; 283(6): 791-4 >From NIH/NLM MEDLINE, AIDSLINE, HealthSTAR NLM Citation ID: 20145264 Full Source Title: JAMA Publication Type: Journal Article Language: English Author Affiliation: Fred Hutchinson Cancer Research Center, Department of Laboratory Medicine, University of Washington School of Medicine, Seattle 98109, USA. Authors: Corey L; Handsfield HH Abstract: Genital herpes can be caused by herpes simplex virus 2 (HSV-2) or, less commonly, by herpes simplex virus 1 (HSV-1). With a seroprevalence of antibodies to HSV-2 of 22% in the general population, genital herpes is 1 of the 3 most prevalent sexually transmitted diseases (STDs) in the United States. A central issue in the public health problem of genital herpes is the high proportion of genital HSV infections that are unrecognized by both patients and clinicians. Persons who are HSV-2 seropositive may be symptomatic but nevertheless fail to recognize genital herpes; they serve as reservoirs for transmission. Physicians and patients must be aware of the subclinical presentation of genital herpes and the potential these patients have for transmitting HSV. Serious consequences of HSV infection include neonatal herpes and increased risk of human immunodeficiency virus transmission. Recommendations to physicians for prevention include using type-specific tests for HSV when screening for other STDs and testing for HSV when evaluating patients with genital ulcers. Researchers must evaluate the performance of type-specific tests and strategies to prevent transmission. Major Subjects: Herpes Genitalis / * Epidemiology / * Prevention & Control / Transmission Additional Subjects: Disease Transmission, Vertical Herpesvirus 2, Human Human HIV Infections / Epidemiology / Transmission Public Health Risk Factors Seroepidemiologic Studies Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. World Health Grant ID: AI-30731 AI NIAID Bookmark URL: /das/journal/view/N/11225119?source=AL,HS,MI At Thu, 26 Oct 2000, ginny lee BSN, GNM wrote: > >At Thu, 26 Oct 2000, Efrain Ramirez wrote: >> >>You are right about cross reaction but read about "Pockit" - type >>specific - highly sensitive - $60 though - >> >Hope this is not a stupid question, but why do titers on all women for >HSV when delivery would be vaginal, even if positive titers, in absence >of lesions? >ginny -- "Do not take life too seriously. You will never get out of it alive." Marianne Williamson Next message: Richard Chudacoff, MD: "Re: Jim Connerth MD" Previous message: Cheri Van Hoover: "Re: ACOG Preventive med guidelines and Hep B" In reply to: ginny lee BSN, GNM: "Re: ACOG Preventive med guidelines and Hep B" Next in thread: Edgardo Rivera: "Re: ACOG Preventive med guidelines and Hep B"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 04:48:31 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.